TP53 and breast carcinoma: However, when analysing TP53 ctDNA separately, patients with postoperative TP53 ctDNA positivity had significantly worse 5‐year OS and DFS than negative patients, a finding consistent with Zhang et al.’s study in advanced breast cancer.25